O T C
Pressure BioSciences, Inc. to Discuss Third Quarter 2019 Financial Results and Provide Business Update

Conference Call Scheduled for Thursday, December 19th at 4:30 pm ET   South Easton, MA, December 18, 2019 — OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that the Company will host a teleconference to discuss its Third Quarter 2019 financial results and to provide a business update

Spanish School of Interactive Digital Media ESAT Places 20 Profiles in Five of the Leading Video Game Developers in Europe, Japan, and the United States

  Valencia, Spain- December 18, 2019 — OTC PR WIRE  — Spanish School of Interactive Digital Media ESAT has placed in the last two years more than 20 students in some of the main video game companies in Europe and Japan, after consolidating itself as the leading European Training Center for Digital Creators. Among more

MobiCard IP Update: USA Patent Trade Mark Office to allow claims for MOBICARD Continuation “child” Patent, Serial No. 16391290

    MobiCard Gives Guidance on Marketing Plan and Agenda for Completing Strategic Objectives, and Lays Out Future Intentions   Cambridge, MA—December 17, 2019  — OTC PR WIRE — Protecting  and enhancing the proprietary inventions of  MobiCard Inc., aka Peer To Peer Network (OTC: PTOP),  is a huge key strategic objective. The Patent Office is

PURA – Puration Raises 2020 Revenue Target From $8 Million

    Dallas, TX – December 17, 2019  — OTC PR WIRE – Puration, Inc. (USOTC: PURA) today announced increasing its 2020 revenue target.  PURA has recently reconfirmed its $4 million revenue target for 2019.  The original 2020 revenue target was $8 million.  The two targets have been based primarily on the company’s current production

ALYI – Alternet Systems Confirms Thursday London Update

  Dallas, TX – December 17, 2019 — OTC PR WIRE –– Alternet Systems, Inc. (USOTC: ALYI) today confirmed an update scheduled for Thursday this week, December 19th, 2019 to review the outcome of the upcoming strategic meetings in London going on now. The company CEO, Randell Torno is in London to advance a developing

Sun Kissed Acquisition, Hakuna, Launches New Premium Products for Holiday Shopping Season

    NEW YORK, December 17, 2019  — OTC PR WIRE – Sun Kissed Industries Inc. (OTCMKTS: SKDI) (“Sun Kissed”, “SKDI”, or the “Company”), an emerging leader in the CBD Food and Beverage marketplace, is excited to announce that its acquisition target (pending closing of already fully-executed agreement) and soon-to-be wholly-owned subsidiary, Hakuna Supply/Products Group,

KALY Announces Anchor Investor In Cannabis Biopharmaceutical Technology At $50 Million Valuation

  Dallas, TX – December 17, 2019  — OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (OTC Pink: KALY) (“KALY”) today announced an anchor investor in its biopharmaceutical technology.  KALY recently announced restructuring its cannabis biopharmaceutical business as part of a strategy to facilitate a strategic investment at a $50 million valuation.  KALY

USMJ Adds Visa To Mastercard and Discover For Online Payments

  Dallas, Texas – December 16, 2019 — OTC PR WIRE – North American Cannabis Holdings, Inc. (OTC PINK: USMJ) (“USMJ”) today announced it now accepts VISA for online purchases from the company’s eCommerce site www.USMJ.com.     Purchases can now be made using Mastercard, Discover or VISA.  The company also accepts e-checks.  USMJ’s eCommerce

Grand Havana, an Iconic Old Havana-Style Coffee Brand Based in Miami Launches New Product Line, Website and E-Shop

  Miami, Fla. — December 16, 2019  —  OTC PR WIRE — Grand Havana (OTC Pink: GHAV), a Miami based-coffee brand bringing the essence, nostalgia and traditions of the 1950s golden age of Old Havana to consumers, is pleased to announce the company has launched a new website at grandhavanacoffee.com. Newly designed and featuring an

Immune Therapeutics Announces Plan to Acquire Aletheia Therapeutics to Create a New Precision Oncology Company

The Planned Acquisition Would Enhance the Management Team, Provide Capital and Bring Additional Oncology Assets to Immune’s Pipeline   ORLANDO, Fla., December 16th, 2019  — OTC PR WIRE — Immune Therapeutics, Inc. (OTCQB: IMUN) (“Immune” “IMUN” or the “Company”) and Aletheia Therapeutics Corp. (“Aletheia”), a privately held development-stage oncology therapeutics company, today announced that Immune

Contact Us

  • 707-OTC-WIRE (707-682-9473)
  • cs@otcprwire.com

All Rights Reserved © 2019